Godavari Drugs P/B Ratio
Godavari Drugs (GODAVARI) P/B ratio is 1.94 (Moderate), book value per share ₹53.75 vs Healthcare average P/B of -0.94 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see GODAVARI screener.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
GODAVARI P/B Ratio — Valuation Insights & Book Value Analysis
Godavari Drugs price-to-book ratio interpretation, valuation status and historical context — current P/B 1.94 (Moderate). View GODAVARI 52-week high low for the annual high/low range and current price position.
- Trading at premium to sector average PB of -0.94
Godavari Drugs P/B Ratio Historical Trend
GODAVARI annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with Godavari Drugs valuation methods to assess whether the stock is under or overvalued.
GODAVARI Historical P/B Ratio — Book Value Per Share & Year-End Price
Godavari Drugs annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 1.43 | ₹53.75 | ₹76.83 | ₹43 | Moderate |
| 2024 | 2.24 | ₹48.75 | ₹109.35 | ₹39 | Moderate |
| 2023 | 2.18 | ₹41.25 | ₹90.06 | ₹33 | Moderate |
| 2022 | 2.53 | ₹37.5 | ₹94.90 | ₹30 | Moderate |
| 2021 | 2.09 | ₹30.0 | ₹62.65 | ₹24 | Moderate |
GODAVARI vs Healthcare Peers — P/B Ratio Comparison
Godavari Drugs P/B 1.94 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |